Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 9—September 2026

Dispatch

Genomic and Epidemiologic Insights into Ongoing Measles Outbreak, Israel, 2025–2026

Efrat Bucris1, Neta S. Zuckerman1, Tal Levin, Yara Kanaaneh, Oran Erster, Victoria Indenbaum, Keren Friedman, Danit Sofer, Eli Schwartz, Elena Chernin, Or Kriger, Rana Shibli, Sharon Elroi Prais, Zohar Mor, Nitza Abramson, Michal Savion, Naama Nuss, Ady Cohen Golan, Eva Avramovich, Dror Yakir, Liora Guy David, Efrat Rorman, Yaniv LustigComments to Author , and National Measles Working Group,2
Author affiliation: Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Ramat-Gan, Israel (E. Bucris, N.S. Zuckerman, T. Levin, Y. Kanaaneh, O. Erster, V. Indenbaum, K. Friedman, D. Sofer, Y. Lustig); Gray Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel (N.S. Zuckerman, Y. Lustig); The Center for Geographic Medicine and Tropical Diseases, The Chaim Sheba Medical Center, Tel Hashomer, Israel (E. Schwartz); Ministry of Health Division of Epidemiology, Jerusalem, Israel (E. Chernin, O. Kriger, R. Shibli, S.E. Prais); Health Intelligence, Ministry of Health, Jerusalem (S.E. Prais, D. Yakir, L.G. David); Program for Public Health, Ashkelon Academic College, Ashkelon, Israel (Z. Mor); Jerusalem Department of Health, Ministry of Health, Jerusalem (Z. Mor, N. Abramson); Tel Aviv Department of Health, Ministry of Health, Tel-Aviv (M. Savion, N. Nuss); Central District Health Bureau, Ramla, Israel (A.C. Golan, E. Avramovich); Ministry of Health Department of Laboratories, Jerusalem (E. Rorman)

Main Article

Table

Patient data from investigation of genomic and epidemiologic insights into ongoing measles outbreak, Israel, 2025–2026*

Patient no. Case ID Symptom onset date Date of return Country of 
infection Epidemiologic data Sequence available Genotype
1 597/25 2025 Apr 5 2025 Mar 30 Serbia Transmission chain of 2 cases Y D8
2 681/25 2025 Apr 10 2025 Apr 4† Belgium Index case N NA
3 651/25 2025 Apr 16 2025 Apr 3 Vietnam Single imported case Y B3
4 835/25 2025 Apr 30 2025 Apr 21 Russia Transmission chain of 2 cases Y B3
5 1813/25 2025 Jun 15 2025 Jun 11 Belgium NA Y B3
6 1929/25 2025 Jul 10 2025 Jul 5 Thailand Transmission chain of 2 cases Y D8
7 3067/25 2025 Aug 26 2025 Aug 22 Poland Virus likely acquired in Israel Y B3
8 3425/25 2025 Oct 2 2025 Sep 30 Ukraine NA N NA
9 4319/25 2025 Oct 3 2025 Oct 10 Poland Single import-associated case N NA
10 4130/25 2025 Oct 31 NA Ethiopia Virus likely acquired in Israel Y B3
11 5745/25 2025 Nov 5 2025 Oct 22 India Single import-associated case N NA
12 4988/25 2025 Nov 27 2025 Nov 30 Germany Virus likely acquired in Israel Y B3
13 833/26 2026 Jan 11 2026 Jan 8 Greece NA N NA

*ID, identification; NA, not available.
†Date of return is estimated; a sample from a close contact was sequenced and determined as B3 genotype.

Main Article

1These authors contributed equally to this manuscript.

2Group members are listed at the end of the article.

Page created: July 24, 2026
Page updated: July 24, 2026
Page reviewed: July 24, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external